Lymphangiomatous hamartoma: Cause or bystander of the isolated chylopericardium?  by Zisis, Charalambos et al.
Discussion
Hemangioendothelioma is a rare cardiac tumor, and just a few cases
treated with surgical intervention are reported in the English litera-
ture.1-3 The tumor in the case we report here was huge and clearly
encapsulated by calcification and fibrous connective tissue, which is
why we could enucleate the tumor without difficulty.
Hemangioendothelioma is classified as an intermediate malig-
nancy that sometimes metastasizes and recurs.4,5 This might indi-
cate that we should have undertaken additional therapy, but Allaire
and colleagues4 have reported that irradiation therapy or chemo-
therapy resulted in only palliation, whereas Hongquan and asso-
ciates1 revealed the prognosis of the hemangioendothelioma was
relatively good once it was completely resected. In the present
case, the tumor was successfully enucleated, and therefore we
decided not to undertake additional therapy. The patient was then
followed for about 3 years, with no sign of recurrence or metas-
tasis.
Although it appears to have been clinically benign, this is an
unprecedented giant tumor that showed an unusually proliferative
pattern, and therefore further close follow-up is inevitable.
References
1. Hongquan Y, Hua R, Quancai C, Qi M, Xiaocheng L, Letian X. Cardiac
hemangioendothelioma. J Cardiovasc Surg. 1998;39:655-8.
2. Gasparovic H, Anic D, Saric D, Gasparovic V, Djuric Z, Jelic I.
Surgical excision of a hemangioendothelioma of the left ventricle. Ann
Thorac Surg. 2002;74:914-6.
3. Ichikawa H, Kaneko T, Obayashi T, et al. Surgical treatment of malig-
nant hemangioendothelioma originated from the right atrium. Kyobu
Geka. 1997;50:67-70.
4. Allaire FJ, Grimm CA, Taylor LM, et al. Primary Hemangioendothe-
lioma of the heart. Report of a case treated with irradiation and cyclo-
phosphamide. Rocky Mt Med J. 1964;61:34-7.
5. Marchiano D, Fisher F, Hofstetter S. Epithelioid hemangioendothelioma of
the heart with distant metastases. J Cardiovasc Surg. 1993;34:529-33.
Lymphangiomatous hamartoma: Cause or bystander of the isolated
chylopericardium?
Charalambos Zisis, MD, PhD,a Dimitra Rontogianni, MD, PhD,b Eliana Charalambous, MD,c and
Ion Bellenis, MD, PhD,a Athens and Crete, Greece
Isolated chylopericardium is an extremely rare pathologicentity, and about its cause there is a series of reasons spo-radically reported in the literature. Lymphangiomatoushamartoma, a benign tumor of lymphangiomatous origin
sparsely located exclusively to the mediastinum, has been consid-
ered one of the causes of the chylopericardium.
Clinical Summary
A 25-year-old male smoker of 7 pack-years was referred to our
department from a district hospital for rapidly recurrent peri-
cardial effusion (Figure 1) diagnosed 15 days before and show-
ing no response to medication. During the 2 previous days, this
progressively increasing effusion had caused clinical and echo-
cardiographic features of pericardial tamponade and had been
submitted twice to pericardiocentesis, with removal of 2.5 L
and 800 mL of milky fluid, respectively. The laboratory results
From the Departments of Thoracic Surgerya and Pathology,b Evangelismos
General Hospital, Athens, Greece, and the Intensive Care and Coronary
Care Unit,c “Venizelio” Hospital, Iraklion, Crete, Greece.
Received for publication April 29, 2005; accepted for publication May 20,
2005.
Address for reprints: Charalambos Zisis, MD, PhD, 17A, Patriarchou
Grigoriou str, 166 74 Glyfada, Greece (E-mail: chzisis@otenet.gr).
J Thorac Cardiovasc Surg 2005;130:1201-2
0022-5223/$30.00
Copyright © 2005 by The American Association for Thoracic Surgery
doi:10.1016/j.jtcvs.2005.05.025
Figure 1. Preoperative chest x-ray film demonstrating enlarge-
ment of the cardiac silhouette contour caused by tamponade.
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of the fluid revealed the following: triglycerides, 944 mg/dL;
cholesterol, 76 mg/dL; glucose, 116 mg/dL; total proteins, 3.7
g/dL; and lactic dehydrogenase, 707 U/L. Computed tomogra-
phy of the chest confirmed the pericardial effusion, and the
patient underwent a left anterior thoracotomy for pericardial
window, when loose and flabby tissue anterior to the pericar-
dium was discovered unexpectedly. After a second diagnostic
investigation (Figure 2), access through a median sternotomy
was chosen, and all tissue located at the anterior mediastinum,
which developed diffusely as myxomatoid and adipose tissue
without concrete macroscopic contour, was totally resected
with the adjacent pericardium. The patient continued to receive
total parenteral nutrition for the whole postoperative period
after the first and second operations until drainage entirely
stopped, and the tubes were removed on the 10th postoperative
day. The patient is doing well 1 year after, without any sign of
recurrence, and a small amount of fluid is checked echocardiographi-
cally. The pathologic examination of the specimen showed hyperplas-
tic lymphangiomatous spaces partially with muscular wall and some
others with thin wall developing into the pericardium and the adjacent
fibrous and fatty tissues of the anterior mediastinum. These his-
topathologic findings had the character of lymphangiomatous hamar-
toma and were accompanied by chronic pericarditis and reactive
lymphadenitis in a total of 16 lymph nodes.
Discussion
Isolated chylopericardium has been reported in a series of patho-
logic conditions, such as in chest trauma, in thrombosis or cathe-
terization of the subclavian vein, after cardiac and thoracic surgery
procedures, and in rare tumors, such as lymphatic hamartomas or
lymphangiomas.1 However, the entity of isolated primary idio-
pathic chylopericardium, sporadically reported in the literature if
no obvious cause can be established, remains obscure.2
Diagnosis is usually made by means of the pericardiocentesis in
patients with pericardial effusion, which is demonstrated to be
chylopericardium. Whether it is a primary or secondary chyloperi-
cardium remains to be investigated with the remaining diagnostic
work-up, including computed tomographic scanning and some-
times lymphangioscintigraphy.3 Abnormal communication be-
tween the thoracic duct and the pericardial cavity is supposed to be
the underlying pathophysiologic mechanism. It is practically un-
known in which cases chylopericardium occurs because the prin-
ciple that thoracic duct pressure has to exceed 15 cm of water to
have a reverse flow in lymphatic tributaries is not always true.
Animal ligation experiments have demonstrated that chylopericar-
dium does not necessarily occur, even with an obstruction of the
thoracic duct, because the duct can drain through collaterals to the
azygous venous system.4 In this context lymphangiomatous hamar-
toma possibly has no direct causative relation to the chylopericardium.
Because the lesion is diffuse and ill-defined, total resection is not
easily achievable. The patient had remission of his pericardial
effusion after the pericardial fenestration and during total paren-
teral nutrition, and therefore it is not evident which therapeutic
maneuver helped him more. In our opinion the pericardial fenes-
tration relieved tamponade, the parenteral nutrition diminished the
chylous effusion, and the lymphangiomatous hamartoma was just
the innocent bystander of the disease, the nature and mechanism of
which remain unknown.
Because cases of chylopericardium are extremely rare, the
material is not homogenous, and the management depends on the
particularities of each case, on the underlying pathology, and on
the performance status of the patient.1,2
Consequently, on the basis of the available diagnostic and
therapeutic modalities, it is not feasible to anticipate the most
efficacious way to access a patient with chylopericardium. It seems
that management has to be individualized because in many patients
with mild symptoms, the disease behaves aggressively with recur-
rent episodes, whereas in others with severe clinical features or
cardiac tamponade on arrival, the disease has a benign clinical
course.
The successful outcome of this case does not predict repetitive
favorable prognosis in all similar cases. We might be missing some
critical points in the cause, the pathophysiology, and the underly-
ing causative mechanism of this rare entity.
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Figure 2. Thoracic computed tomographic scan revealing a mass
anterior to the heart and a drainage tube into the pericardial
fenestration to the left.
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